Position in EWTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$27,273,697
+$9,112,184 QoQ
Shares Held
671,270
+16.4% QoQ
Ownership
0.618%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 223 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. EWTX ranks #60 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in EWTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,273,697 | 671,270 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $18,161,513 | 576,556 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $13,887,687 | 559,649 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $9,535,443 | 587,882 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $7,903,990 | 602,898 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $13,347,224 | 606,692 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $16,321,869 | 611,306 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $15,370,236 | 575,880 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $9,161,524 | 508,691 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,111,243 | 499,520 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,973,878 | 363,243 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,976,368 | 344,916 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,630,791 | 339,457 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,041,579 | 306,084 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,832,477 | 316,832 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,350,775 | 238,900 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,729,444 | 217,267 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,851,333 | 293,952 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,617,462 | 302,190 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,918,511 | 115,573 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,703,128 | 126,729 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||